Grifols Debt to Equity Ratio 2012-2018 | GRFS

Current and historical debt to equity ratio values for Grifols (GRFS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Grifols debt/equity for the three months ending September 30, 2018 was 1.47.
Grifols Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $7.11B $4.82B 1.48
2018-06-30 $7.20B $4.74B 1.52
2017-06-30 $6.65B $3.94B 1.69
2017-03-31 $6.75B $4.07B 1.66
2016-12-31 $5.21B $4.13B 1.26
2016-09-30 $5.01B $3.94B 1.27
2016-06-30 $5.10B $3.86B 1.32
2016-03-31 $4.87B $3.64B 1.34
2015-12-31 $5.11B $3.67B 1.39
2015-09-30 $4.89B $3.56B 1.37
2015-06-30 $4.90B $3.40B 1.44
2015-03-31 $5.22B $3.54B 1.47
2014-12-31 $5.52B $3.54B 1.56
2014-09-30 $5.35B $3.37B 1.59
2014-06-30 $5.15B $3.07B 1.68
2014-03-31 $5.13B $3.05B 1.68
2013-12-31 $3.39B $2.80B 1.21
2013-09-30 $3.48B $2.61B 1.33
2013-06-30 $3.52B $2.54B 1.39
2013-03-31 $3.62B $2.59B 1.40
2012-12-31 $3.46B $2.42B 1.43
2012-09-30 $3.30B $2.32B 1.42
2012-06-30 $3.47B $2.36B 1.47
2012-03-31 $3.36B $2.21B 1.52
2011-12-31 $3.91B $2.32B 1.69
2011-09-30 $4.02B $2.26B 1.78
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.614B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.821B 30.37
Takeda Pharmaceutical (TAK) Japan $31.966B 11.83
Ionis Pharmaceuticals (IONS) United States $8.114B 0.00
Neurocrine Biosciences (NBIX) United States $7.658B 496.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.596B 10.90
Sage Therapeutics (SAGE) United States $7.546B 0.00
Nektar Therapeutics (NKTR) United States $7.216B 10.34
Loxo Oncology (LOXO) United States $7.184B 0.00
Tilray (TLRY) United States $7.126B 0.00
Catalent (CTLT) United States $6.121B 25.63
United Therapeutics (UTHR) United States $5.214B 8.53
FibroGen (FGEN) United States $4.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.146B 13.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.102B 21.81
USANA Health Sciences (USNA) United States $2.519B 20.56
Endo (ENDP) Ireland $2.371B 3.63
Ironwood Pharmaceuticals (IRWD) United States $2.342B 0.00
Heron Therapeutics (HRTX) United States $2.155B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.082B 0.00
Portola Pharmaceuticals (PTLA) United States $2.057B 0.00
Xencor (XNCR) United States $2.050B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.005B 24.98
Zogenix (ZGNX) United States $1.972B 0.00
Aerie Pharmaceuticals (AERI) United States $1.898B 0.00
PTC Therapeutics (PTCT) United States $1.701B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.673B 226.00
Theravance Biopharma (TBPH) Cayman Islands $1.527B 0.00
Corcept Therapeutics (CORT) United States $1.363B 20.00
TherapeuticsMD (TXMD) United States $1.344B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.221B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.987B 0.00
Tricida (TCDA) United States $0.971B 0.00
ImmunoGen (IMGN) United States $0.842B 0.00
Radius Health (RDUS) United States $0.833B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.591B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.565B 0.00
Siga Technologies (SIGA) United States $0.562B 0.00
Karyopharm Therapeutics (KPTI) United States $0.559B 0.00
Flexion Therapeutics (FLXN) United States $0.555B 0.00
ChemoCentryx (CCXI) United States $0.554B 43.84
BioSpecifics Technologies Corp (BSTC) United States $0.521B 30.74
GlycoMimetics (GLYC) United States $0.513B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.512B 0.00
Collegium Pharmaceutical (COLL) United States $0.492B 0.00
Forty Seven (FTSV) United States $0.481B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Aptorum Group (APM) China $0.431B 0.00
Translate Bio (TBIO) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.400B 0.00
Lannett Co Inc (LCI) United States $0.386B 3.58
Akebia Therapeutics (AKBA) United States $0.379B 0.00
ArQule (ARQL) United States $0.372B 0.00
KalVista Pharmaceuticals (KALV) United States $0.368B 0.00
Concert Pharmaceuticals (CNCE) United States $0.352B 0.00
CASI Pharmaceuticals (CASI) United States $0.343B 0.00
Tyme Technologies (TYME) United States $0.330B 0.00
Dermira (DERM) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.327B 0.00
Majesco Entertainment (PTE) United States $0.311B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.304B 0.00
Minerva Neurosciences (NERV) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.285B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.281B 10.48
MARKER THERAPEUTICS, INC (MRKR) United States $0.246B 0.00
Mast Therapeutics (SVRA) United States $0.241B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
IMV INC (IMV) Canada $0.225B 0.00
Dova Pharmaceuticals (DOVA) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Aratana Therapeutics (PETX) United States $0.215B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.211B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
Calithera Biosciences (CALA) United States $0.204B 0.00
Aldeyra Therapeutics (ALDX) United States $0.204B 0.00
Xeris Pharmaceuticals (XERS) United States $0.203B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.198B 0.00
ElectroCore (ECOR) United States $0.195B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.195B 0.00
Recro Pharma (REPH) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Redhill Biopharma (RDHL) Israel $0.179B 0.00
Molecular Templates (MTEM) United States $0.171B 0.00
Aquestive Therapeutics (AQST) United States $0.166B 0.00
Zafgen (ZFGN) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Ardelyx (ARDX) United States $0.162B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Ocular Therapeutix (OCUL) United States $0.151B 0.00
Adherex Technologies (FENC) United States $0.151B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.148B 0.00
Neon Therapeutics (NTGN) United States $0.140B 0.00
Jounce Therapeutics (JNCE) United States $0.138B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.134B 0.00
MediWound (MDWD) Israel $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.122B 0.00
DURECT (DRRX) United States $0.120B 0.00
China SXT Pharmaceuticals (SXTC) China $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.118B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.103B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.081B 0.00
Natural Alternatives (NAII) United States $0.080B 7.82
Nivalis Therapeutics (ALPN) United States $0.080B 0.00
Infinity Pharmaceuticals (INFI) United States $0.079B 0.00
Melinta Therapeutics (MLNT) United States $0.077B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.069B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.065B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.063B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.063B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Otonomy (OTIC) United States $0.062B 0.00
KemPharm (KMPH) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Genocea Biosciences (GNCA) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Achaogen (AKAO) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Lipocine (LPCN) United States $0.036B 0.00
Capnia (SLNO) United States $0.036B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
NOVAN INC (NOVN) United States $0.031B 0.00
NanoViricides (NNVC) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Biomerica (BMRA) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
Can-Fite Biopharma (CANF) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Trillium Therapeutics (TRIL) Canada $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.016B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
VAXART, INC (VXRT) United States $0.014B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 1.19
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.009B 0.00
Intellipharmaceutics (IPCI) Canada $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00